PRESS RELEASE published on 02/22/2024 at 15:00, 1 year 1 month ago Sustained Acoustic Medicine Helps Veteran Triathlete Maintain Peak Performance and Rapid Recovery Claudia McCoy, top-tier triathlete and USAT Certified Triathlon Coach, endorses the sam® wearable ultrasound for injury recovery and training. Developed by ZetrOZ Systems, the sustained acoustic medicine aids in faster recovery without surgery or pain medication ZetrOZ Systems Sustained Acoustic Medicine Wearable Ultrasound Claudia McCoy Triathlete
BRIEF published on 02/22/2024 at 15:00, 1 year 1 month ago Claudia McCoy, champion triathlete, returns to the top thanks to ZetrOZ Systems' sam® technology ZetrOZ Systems Claudia McCoy Triathlon Sam® Technology Sports Recovery
PRESS RELEASE published on 02/13/2024 at 18:45, 1 year 2 months ago ZetrOZ Systems to Showcase Sustained Acoustic Medicine at the American Academy of Orthopedic Surgeons Annual Meeting ZetrOZ Systems to display sam® wearable ultrasound unit at AAOS 2024 annual meeting, showcasing FDA-cleared treatment for soft tissue healing and injury recovery. Technology complements orthopedic procedures ZetrOZ Systems Soft Tissue Healing Orthopedic Surgery Sam® Wearable Ultrasound Unit AAOS 2024 Annual Meeting
PRESS RELEASE published on 01/24/2024 at 15:00, 1 year 2 months ago ZetrOZ Systems to Demonstrate sam Wearable Ultrasound Unit at Las Vegas Conference ZetrOZ Systems, the inventor of sustained acoustic medicine, will be demonstrating its sam® X1 wearable ultrasound unit for healthcare providers at The Las Vegas Regenerative Medicine and MSK Ultrasound Course. This event aims to train orthopedic surgeons, sports medicine physicians, physical therapists, and other health practitioners in the latest musculoskeletal ultrasound and regenerative medicine technologies. Dr. Don Buford, a top orthopedic surgeon, praises ZetrOZ Systems' technology for its ability to promote soft tissue healing, and the conference will feature a session focusing on the evidence-based best practices in orthopedics, including therapeutic ultrasound use. ZetrOZ Systems' long-duration ultrasound treatment technology has been documented in numerous peer-reviewed publications and clinical studies, aligning well with the conference's goals. The company's founder and CEO, George K. Lewis, aims to educate a wider clinical audience on the value of sustained acoustic medicine and its application in treating soft tissue injuries. Sustained Acoustic Medicine Wearable Ultrasound Regenerative Medicine Orthopedic Surgeons Musculoskeletal Ultrasound
PRESS RELEASE published on 01/22/2024 at 16:15, 1 year 2 months ago ZetrOZ Systems to Showcase sam(R) Ultrasound Treatment Technology at the 2024 Big Sky Sports Medicine Conference ZetrOZ Systems, the makers of the sam® wearable ultrasound unit, will be presenting its sustained acoustic medicine technology at the 26th annual Big Sky Sports Medicine Conference. The presentations will focus on the effectiveness of sustained acoustic medicine in soft tissue healing, showcasing the sam X1 and sam 2.0 devices, both cleared by the FDA for expanded indications to treat soft tissue injuries and knee osteoarthritis. This ground-breaking treatment has been clinically validated in over 40 studies and is designed to accelerate soft tissue healing and relieve pain without invasive procedures. Find out more at www.samrecover.com. ZetrOZ Systems Sustained Acoustic Medicine Soft Tissue Healing Sam Wearable Ultrasound Unit Big Sky Sports Medicine Conference
PRESS RELEASE published on 01/16/2024 at 17:00, 1 year 2 months ago The Orthobiologic Institute and ZetrOZ Systems Launch 2024 Clinical Education Program on Non-Opioid and Non-Surgical Soft-Tissue Regenerative Techniques for Clinicians Clinical education director Dr. Rajiv Mallipudi will lead an exclusive webinar series with The Orthobiologic Institute to train clinicians on sustained acoustic medicine and its effectiveness in soft tissue healing using the sam® ultrasound unit. The program will explore the science behind sam®, treatment protocols, and its applications in sports-related injuries, offering standardized guidelines for effective use. This collaboration aims to advance the understanding of regenerative ultrasound technology and its impact on healthcare standards. Clinical Education Sustained Acoustic Medicine Sam® Ultrasound Soft Tissue Healing Orthobiologics
PRESS RELEASE published on 01/09/2024 at 18:45, 1 year 3 months ago ZetrOZ Systems’ sam 2.0 Wearable Ultrasound Unit Receives New FDA Clearance for Expanded Medical Indications ZetrOZ Systems' sam® 2.0 long-duration wearable ultrasound unit has received clearance from the U.S. Food and Drug Administration for expanded indications to treat soft tissue injuries and knee osteoarthritis, making the sustained acoustic medicine device more accessible to a wider range of medical conditions. The FDA's decision signifies the device's safety and effectiveness, paving the way for increased utilization in both professional sports and general population healthcare. The company's founder and CEO, George K. Lewis, highlights the significance of the FDA clearance, emphasizing the numerous studies demonstrating the technology's efficacy in treating injuries without the need for oral medication, corticosteroids, or surgery. ZetrOZ Systems Sam® 2.0 Wearable Ultrasound Unit Sustained Acoustic Medicine Technology FDA Clearance
PRESS RELEASE published on 12/15/2023 at 21:00, 1 year 3 months ago ZetrOZ Systems Supports 2023 Major League Soccer Medical Symposium and Highlights Sustained Acoustic Medicine Innovation
PRESS RELEASE published on 12/06/2023 at 20:30, 1 year 4 months ago ZetrOZ Systems Sponsors Event for Athletic Trainers at Major League Baseball Winter Meetings ZetrOZ Systems to present on sustained acoustic medicine technology's effectiveness in promoting soft tissue healing at the Professional Baseball Athletic Trainers Society (PBATS) meeting during Major League Baseball's Winter Meetings 2023 ZetrOZ Systems Wearable Ultrasound Unit Sustained Acoustic Medicine Soft Tissue Healing PBATS Meeting
PRESS RELEASE published on 12/01/2023 at 18:45, 1 year 4 months ago ZetrOZ Systems Partners with Military Sports Medicine Providers Delivering Advanced Healing Technologies ZetrOZ Systems will showcase its sam® wearable ultrasound unit at SOMOS 2023 to demonstrate the proven ability of sustained acoustic medicine technology to speed soft tissue healing, reducing the need for surgery and opioids ZetrOZ Systems Sustained Acoustic Medicine Technology Soft Tissue Healing Sam® Wearable Ultrasound SOMOS 2023
Published on 04/12/2025 at 15:45, 1 day 15 hours ago New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 2 days 5 hours ago Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 2 days 7 hours ago Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/11/2025 at 23:45, 2 days 7 hours ago Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties
Published on 04/14/2025 at 07:17, 13 minutes ago Photon Energy Announces Third Investment in RayGen to Accelerate Global Technology Deployment
Published on 04/14/2025 at 07:15, 16 minutes ago SoftwareOne announces amendments to existing Crayon total return swap agreement
Published on 04/14/2025 at 07:00, 30 minutes ago Swiss Re publishes its 2024 Financial Condition Report
Published on 04/14/2025 at 07:00, 30 minutes ago The Burkhalter Group posts excellent results for the 2024 financial year
Published on 04/14/2025 at 07:00, 31 minutes ago SoftwareOne announces strong uptake of its recommended voluntary share and cash offer for Crayon during the initial acceptance period
Published on 04/11/2025 at 18:30, 2 days 13 hours ago Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:00, 2 days 13 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:45, 2 days 13 hours ago NFL Biosciences presents its 2024 annual results and provides an update on its clinical program
Published on 04/11/2025 at 13:49, 2 days 17 hours ago Statement about the number of shares composing the share capital and the number of voting rights as at March 31, 2025
Published on 04/11/2025 at 13:36, 2 days 17 hours ago Number of shares and voting rights - March 2025 (In French only)